UNSPSC 51282939: Piromidic acid

This classification denotes a urinary anti-infective agent and quinolone antibiotic with the molecular formula C14H16N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3I12WH4EWF, chemically known as 8-ethyl-5-oxo-2-(1-pyrrolidinyl)-5,8-dihydropyrido(2,3-d)pyrimidine-6-carboxylic acid but generally known as piromidic acid, which bears US NIH Compound Identifier 4855. European Medicines Agency schedules Piromidic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09934MIG.

UNSPSC 51282939 Piromidic acid is a Commodity code that appears in state and local procurement records with minimal recent activity aligned to its nominal scope. The two recent opportunities tagged to this code do not substantively involve piromidic acid; instead, they cover pharmaceutical warehouse supply of common antibiotics (Doxycycline Hyclate and Ciprofloxacin Hydrochloride) and procurement of naloxone and drug deactivation systems for community health support. The mismatch between the code's name and the actual goods being solicited suggests either miscoding in the source system or use of a parent or sibling code to capture broader pharmaceutical supply categories. State and local health departments and counties are the primary issuing bodies visible in recent records, though the volume and specificity of activity under this particular code remains unclear from available solicitation data.

The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 (Bid 26-482DPH-PREPD-B-53392), covering antibiotic supply over a three-year term. Seminole County, Florida posted an IFB in June 2026 (IFB60459723LAS) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly delivery to the Seminole County Community Health Building, though the response deadline listed (July 26, 2023) appears to reflect a data error. Recent solicitation activity clusters in Florida and Illinois, though the code shows no clear geographic concentration and limited recent volume overall. Vendors should verify whether piromidic acid itself or related pharmaceutical compounds are being sourced under this code in their target jurisdictions, as the current records suggest the code may be misapplied to broader health department supply categories.